Ars Pharmaceuticals Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.11

-0.04 (-0.96%)

As of Sep 20, 10:16 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +1,503.6% upside

Low Target $44.11

Average Target $65.91

High Target $67.85

Current Price $4.11

Current
$4.11

Target
$65.91

$44.11 $65.91 avg $67.85

Scenario Analysis

Bear Case

$44.11

973.2%

Low target

Base Case

$65.91

+1,503.6%

Avg target

Bull Case

$67.85

+1,550.9%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$13.15

-68.7% from high

52-Week Low

$4.12

+-0.2% from low

Target vs 52W High

$65.91

+401.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%